Novel radionuclides for use in Nuclear Medicine in Europe: where do we stand and where do we go?

Novel radionuclides for use in Nuclear Medicine in Europe: where do we stand and where do we go?

Abstract Background In order to support the ongoing research across Europe to facilitate access to novel radionuclides, the PRISMAP consortium (European medical radionuclides programme) was established to offer the broadest catalog of non-conventional radionuclides for medical and translational rese...

Full description

Bibliographic Details
Main Authors: Maija Radzina, Laura Saule, Edgars Mamis, Ulli Koester, Thomas Elias Cocolios, Elina Pajuste, Marika Kalnina, Kristaps Palskis, Zoe Sawitzki, Zeynep Talip, Mikael Jensen, Charlotte Duchemin, Kirsten Leufgen, Thierry Stora
Format: Article
Language:English
Published: SpringerOpen 2023-10-01
Series:EJNMMI Radiopharmacy and Chemistry
Subjects:
Radionuclides
Diagnostic
Therapy
PET/CT
PRISMAP programme
Online Access:https://doi.org/10.1186/s41181-023-00211-5

Internet

https://doi.org/10.1186/s41181-023-00211-5

Similar Items